Center for Substance Abuse Prevention; Notice of Meeting, 8492 [2018-03897]

Download as PDF 8492 Federal Register / Vol. 83, No. 39 / Tuesday, February 27, 2018 / Notices Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Cheryl M. Corsaro, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2204, MSC 7890, Bethesda, MD 20892, (301) 435– 1045, corsaroc@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Biobehavioral Regulation, Stress, and Sleep. Date: March 20, 2018. Time: 2:00 p.m. to 3:15 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Wind Cowles, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3172, Bethesda, MD 20892, 301–437–7872, cowleshw@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 21, 2018. Sylvia L. Neal, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–03869 Filed 2–26–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration daltland on DSKBBV9HB2PROD with NOTICES Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory Board (DTAB) will meet in person and via web conference on March 20, 2018, from 10:00 a.m. to 3:00 p.m. EDT, and March 21, 2018 from 10:00 a.m. to 2:00 p.m. EDT. The Board will meet in open session on March 20, 2018, from 10:00 a.m. to 1:00 p.m., to provide updates on the Mandatory Guidelines for Federal Workplace Drug Testing Programs, hear from our federal partners and early observations from the synthetic opioid testing implementation, review research data on a marijuana vaping study, and a brief update on the Medical Review Officer (MRO) Guidance Manual and VerDate Sep<11>2014 19:49 Feb 26, 2018 Jkt 244001 2018 MRO Guidance Manual Case Studies. The board will meet in closed session on March 20, 2018, from 2:00 p.m. to 3:00 p.m. EDT and on March 21, 2018, from 10:00 a.m. to 2:00 p.m. EDT to discuss the proposed Mandatory Guidelines for Federal Workplace Drug Testing Programs (oral fluid), and the Mandatory Guidelines for Federal Workplace Drug Testing Programs (hair specimen). Therefore, these portions of the meeting are closed to the public as determined by the Assistant Secretary, SAMHSA, in accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, Section 10(d). Meeting registration information can be completed at https://snacregister. samhsa.gov/MeetingList.aspx. Web conference and call information will be sent after completing registration. Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees website, https:// www.samhsa.gov/about-us/advisorycouncils/drug-testing-advisory-boarddtab or by contacting the Designated Federal Officer, CAPT Sean J. Belouin, USPHS. Committee Name: Substance Abuse and Mental Health Services Administration’s Center for Substance Abuse Prevention Drug Testing Advisory Board. Dates/Time/Type: March 20, 2018, from 10:00 a.m. to 1:00 p.m., EDT: Open. March 20, 2018, from 2:00 p.m. to 3:00 p.m., EDT: Closed. March 21, 2018, from 10:00 a.m. to 2:00 p.m., EDT: Closed. Place: Parklawn Building, Room 5A03, 5600 Fishers Lane, Rockville, Maryland 20857. Contact: CAPT Sean J. Belouin, USPHS, Senior Pharmacology and Regulatory Policy Advisor, Division of Workplace Programs, 5600 Fishers Lane, Room 16N06D, Rockville, Maryland 20857, Telephone: (240) 276–2600, Email: sean.belouin@samhsa.hhs.gov. Charles LoDico, Chemist. [FR Doc. 2018–03897 Filed 2–26–18; 8:45 am] BILLING CODE 4162–20–P PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2018–0139] National Maritime Security Advisory Committee U.S. Coast Guard, Department of Homeland Security. ACTION: Notice of Federal Advisory Committee meeting. AGENCY: The National Maritime Security Advisory Committee will meet in Oakland, California, to review and discuss various issues relating to national maritime security. All meetings will be open to the public. DATES: Meetings. The Committee will meet on Tuesday, March 20, 2018, from 12 Noon to 5 p.m. and on Wednesday, March 21, 2018, from 8 a.m. to 1 p.m. These meetings may close early if all business is finished. Comments and supporting documentation. To ensure your comments are reviewed by Committee members comment before the meetings, submit your written comments no later than March 12, 2018. ADDRESSES: The meeting will be held the Port of Oakland conference room, 530 Water Street, Oakland, CA 94607. https://www.portofoakland.com/. This meeting will be broadcast via a web enabled interactive online format and teleconference line. To participate via teleconference, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section no later than March 12, 2018. Additionally, if you would like to participate in this meeting via the online web format, please log onto https://share.dhs.gov/ nmsac/ and follow the online instructions to register for this meeting. If you encounter technical difficulties, contact Mr. Ryan Owens at (202) 302– 6565. For information on facilities or services for individuals with disabilities, or to request special assistance at the meetings, contact the individual listed in FOR FURTHER INFORMATION CONTACT below as soon as possible. Written comments must be submitted using the Federal eRulemaking Portal: https://www.regulations.gov. If you encounter technical difficulties, contact the individual in the FOR FURTHER INFORMATION CONTACT section of this document. Instructions: You are free to submit comments at any time, including orally SUMMARY: E:\FR\FM\27FEN1.SGM 27FEN1

Agencies

[Federal Register Volume 83, Number 39 (Tuesday, February 27, 2018)]
[Notices]
[Page 8492]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-03897]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory 
Board (DTAB) will meet in person and via web conference on March 20, 
2018, from 10:00 a.m. to 3:00 p.m. EDT, and March 21, 2018 from 10:00 
a.m. to 2:00 p.m. EDT.
    The Board will meet in open session on March 20, 2018, from 10:00 
a.m. to 1:00 p.m., to provide updates on the Mandatory Guidelines for 
Federal Workplace Drug Testing Programs, hear from our federal partners 
and early observations from the synthetic opioid testing 
implementation, review research data on a marijuana vaping study, and a 
brief update on the Medical Review Officer (MRO) Guidance Manual and 
2018 MRO Guidance Manual Case Studies.
    The board will meet in closed session on March 20, 2018, from 2:00 
p.m. to 3:00 p.m. EDT and on March 21, 2018, from 10:00 a.m. to 2:00 
p.m. EDT to discuss the proposed Mandatory Guidelines for Federal 
Workplace Drug Testing Programs (oral fluid), and the Mandatory 
Guidelines for Federal Workplace Drug Testing Programs (hair specimen). 
Therefore, these portions of the meeting are closed to the public as 
determined by the Assistant Secretary, SAMHSA, in accordance with 5 
U.S.C. 552b(c)(4) and (9)(B), and 5 U.S.C. App. 2, Section 10(d).
    Meeting registration information can be completed at https://snacregister.samhsa.gov/MeetingList.aspx. Web conference and call 
information will be sent after completing registration. Meeting 
information and a roster of DTAB members may be obtained by accessing 
the SAMHSA Advisory Committees website, https://www.samhsa.gov/about-us/advisory-councils/drug-testing-advisory-board-dtab or by contacting the 
Designated Federal Officer, CAPT Sean J. Belouin, USPHS.
    Committee Name: Substance Abuse and Mental Health Services 
Administration's Center for Substance Abuse Prevention Drug Testing 
Advisory Board.
    Dates/Time/Type:
    March 20, 2018, from 10:00 a.m. to 1:00 p.m., EDT: Open.
    March 20, 2018, from 2:00 p.m. to 3:00 p.m., EDT: Closed.
    March 21, 2018, from 10:00 a.m. to 2:00 p.m., EDT: Closed.
    Place: Parklawn Building, Room 5A03, 5600 Fishers Lane, Rockville, 
Maryland 20857.
    Contact: CAPT Sean J. Belouin, USPHS, Senior Pharmacology and 
Regulatory Policy Advisor, Division of Workplace Programs, 5600 Fishers 
Lane, Room 16N06D, Rockville, Maryland 20857, Telephone: (240) 276-
2600, Email: [email protected].

Charles LoDico,
Chemist.
[FR Doc. 2018-03897 Filed 2-26-18; 8:45 am]
 BILLING CODE 4162-20-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.